The Endologix ® AFX ® 2 Endovascular AAA System is indicated for endovascular treatment in patients with AAA using a surgical vascular access technique or a bilateral percutaneous …

Our EVAR portfolio offers disruptive innovative options to treat the clinical needs of your patients with specialized AAA anatomies. Experience the differentiation of our EVAR Portfolio and …

The AFX2 Endovascular AAA System is indicated for endovascular treatment in patients with AAA using a surgical vascular access technique. The devices are indicated for patients with …

EVAR using the AFX stent graft in very narrow aortic bifurcations at a mean diameter of 15.8 mm is safe and generates a satisfying short- and long-term patient outcome. Specifically, the …

On December 6, 2022, the FDA approved new labeling for the currently available product, the AFX2 Endovascular AAA System (AFX2), that includes information to better inform patients …

Aug 31, 2021 · EVAR is a complex intervention and no endograft is completely safe or completely effective Risk-benefit analysis should include all relevant failure modes

With a low-profile hydrophilic sheath, next-generation expanded polytetrafluoroethylene (ePTFE) graft technology, and a precise deployment mechanism for accuracy, the device system offers …

Jul 8, 2017 · Endovascular abdominal aortic aneurysm repair (EVAR) with the AFX Endovascular AAA system is performed for symptomatic or asymptomatic aortic aneurysm greater than 5.5 …

In recent years, endovascular aortic repair (EVAR) has emerged as a safe and valid option for treatment of abdominal aortic aneurysms (AAAs) (Multimedia Appendix 1). The AFX 2 …

AFX. The AFX Endovascular AAA System (Endologix, Inc., Irvine, CA) is built on the proven concept of anatomical fixation, wherein the bifurcated graft rests on the aortoiliac bifurcation. …